Evolving Paradigms in the Management of Primary Immune Thrombocytopenia in Adults: From Corticosteroids to Targeted Therapies
Massimo Martino, Laura Giordano, Maria Bruna Greve, Violetta Marafioti, Caterina Alati · 2026
Read Evolving Paradigms in the Management of Primary Immune Thrombocytopenia in Adults: From Corticosteroids to Targeted Therapies by Massimo Martino, Laura Giordano, Maria Bruna Greve, Violetta Marafioti, Caterina Alati (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13568485.txt.
Description
Five reviewers trace how care for a blood platelet disorder in adults has moved from blunt steroids to targeted drugs, in a review published in 2026. In this disease, the immune system destroys platelets and slows their making, leaving counts low. Bleeding was long the chief worry, but patient reports now stress fatigue and poor life quality just as strongly. The review covers primary disease in adults.
Steroids remain the first step, with a small set of older second options behind them. Newer drugs aim at exact immune parts, from B-cell signals to the recycling system that clears antibodies. Trials of these agents look promising, but the best order and mix of drugs is still unsettled. The authors urge doctors to weigh symptoms patients feel, safety, and personal preference alongside platelet counts when they choose care.
Catalog record
| CREATOR | Massimo Martino, Laura Giordano, Maria Bruna Greve, Violetta Marafioti, Caterina Alati |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |